| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |